• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

探讨 CD109 表达在女性外阴鳞状细胞癌中的预后意义。

Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.

机构信息

Department of Obstetrics and Gynecology, Dogubeyazıt State Hospital, Aǧrı ; Department of Obstetrics and Gynecology, Atatürk Training and Research Hospital, izmir.

出版信息

Onco Targets Ther. 2013 Jun 7;6:621-7. doi: 10.2147/OTT.S41069. Print 2013.

DOI:10.2147/OTT.S41069
PMID:23776335
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3681417/
Abstract

OBJECTIVE

The goal of this study was to investigate the between cluster of differentiation 109 (CD109) expression and tumor diameter, invasion depth, tumor grade, presence of lymph-node metastasis, and overall survival in patients with vulvar squamous cell carcinoma, which is the most common type of vulvar cancer.

METHOD

Twenty-six patients who underwent an operation for vulvar cancer between 1999 and 2009 in our clinic were included in this study. Immunohistochemical staining was performed on formalin-fixed and paraffin-embedded tissue.

RESULT

Tumor diameter was not found to be significantly associated with CD109 expression, intensity of cytoplasmic staining, or combined score (P = 0.325, P = 0.169, P = 0.352, respectively). Invasion depth and combined score were also not significantly correlated with CD109 expression (P = 0.324 and P = 0.174 respectively). There was a negative correlation between invasion depth and the intensity of cytoplasmic staining (P = 0.042). There was no significant correlation between tumor stage and CD109 expression, the intensity of cytoplasmic staining, and the combined score (P = 0.574, P = 0.389, P = 0.605, respectively). A significant positive correlation was observed between tumor grade and CD109 expression, the intensity of cytoplasmic staining, and the combined score (P = 0.003, P = 0.018, P = 0.008, respectively). No significant difference was found between the percentages of CD109 expression in patients with positive (48%) and negative (11%) lymph nodes (P = 0.058). The percentage of CD109 expression did not significantly differ in relation to overall survival (P = 0.483).

CONCLUSION

Comprehensive and more extensive studies are needed to examine the relationship between CD109 expression and vulvar malignant lesions.

摘要

目的

本研究旨在探讨 CD109 在簇分化 109(CD109)表达与肿瘤直径、浸润深度、肿瘤分级、淋巴结转移和外阴鳞状细胞癌患者总生存之间的关系,外阴鳞状细胞癌是外阴最常见的癌症类型。

方法

本研究纳入了 1999 年至 2009 年在我院接受外阴癌手术的 26 例患者。对福尔马林固定和石蜡包埋组织进行免疫组织化学染色。

结果

肿瘤直径与 CD109 表达、细胞质染色强度或联合评分均无显著相关性(P=0.325、P=0.169、P=0.352)。浸润深度和联合评分也与 CD109 表达无显著相关性(P=0.324 和 P=0.174)。浸润深度与细胞质染色强度呈负相关(P=0.042)。肿瘤分期与 CD109 表达、细胞质染色强度和联合评分均无显著相关性(P=0.574、P=0.389、P=0.605)。肿瘤分级与 CD109 表达、细胞质染色强度和联合评分呈显著正相关(P=0.003、P=0.018、P=0.008)。阳性(48%)和阴性(11%)淋巴结患者的 CD109 表达率无显著差异(P=0.058)。CD109 表达率与总生存率无显著差异(P=0.483)。

结论

需要进行更广泛的综合研究,以检验 CD109 表达与外阴恶性病变之间的关系。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09f6/3681417/45fb119c6364/ott-6-621Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09f6/3681417/32fa3442f093/ott-6-621Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09f6/3681417/45fb119c6364/ott-6-621Fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09f6/3681417/32fa3442f093/ott-6-621Fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/09f6/3681417/45fb119c6364/ott-6-621Fig2.jpg

相似文献

1
Investigation of prognostic significance of CD109 expression in women with vulvar squamous cell carcinoma.探讨 CD109 表达在女性外阴鳞状细胞癌中的预后意义。
Onco Targets Ther. 2013 Jun 7;6:621-7. doi: 10.2147/OTT.S41069. Print 2013.
2
Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.血清 CD109 水平反映头颈部鳞状细胞癌的淋巴结转移状态。
Cancer Med. 2021 Feb;10(4):1335-1346. doi: 10.1002/cam4.3737. Epub 2021 Feb 9.
3
Quantitation of proliferation-associated markers Ag-NOR and Ki-67 does not contribute to the prediction of lymph node metastases in squamous cell carcinoma of the vulva.增殖相关标志物银染核仁组成区(Ag-NOR)和Ki-67的定量分析无助于预测外阴鳞状细胞癌的淋巴结转移。
Hum Pathol. 1996 Aug;27(8):807-11. doi: 10.1016/s0046-8177(96)90453-0.
4
Occult lymph node metastases in early stage vulvar carcinoma patients.早期外阴癌患者的隐匿性淋巴结转移
Gynecol Oncol. 2005 Nov;99(2):383-7. doi: 10.1016/j.ygyno.2005.06.023. Epub 2005 Jul 26.
5
CD109 expression is upregulated in penile squamous cell carcinoma.CD109在阴茎鳞状细胞癌中表达上调。
Oncol Lett. 2017 Nov;14(5):6012-6016. doi: 10.3892/ol.2017.6975. Epub 2017 Sep 15.
6
[Investigation of individualized treatment based on sentinel lymph node biopsy for early-stage vulvar cancer].基于前哨淋巴结活检的早期外阴癌个体化治疗研究
Zhonghua Fu Chan Ke Za Zhi. 2015 Aug;50(8):596-602.
7
CD109 is a potential target for triple-negative breast cancer.CD109是三阴性乳腺癌的一个潜在靶点。
Tumour Biol. 2014 Dec;35(12):12083-90. doi: 10.1007/s13277-014-2509-5. Epub 2014 Aug 23.
8
Epithelial-mesenchymal transition (EMT) in vulvar cancer with and without inguinal lymph node involvement.外阴癌中腹股沟淋巴结受累与否的上皮-间充质转化(EMT)。
J Cancer Res Clin Oncol. 2022 May;148(5):1183-1193. doi: 10.1007/s00432-021-03715-2. Epub 2021 Sep 8.
9
CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells.CD109是表皮生长因子受体(EGFR)表达、信号传导及鳞状细胞癌细胞致瘤性的关键决定因素。
Cancers (Basel). 2022 Jul 28;14(15):3672. doi: 10.3390/cancers14153672.
10
CD109 expression in tumor cells and stroma correlates with progression and prognosis in pancreatic cancer.肿瘤细胞和基质中CD109的表达与胰腺癌的进展和预后相关。
Virchows Arch. 2022 Apr;480(4):819-829. doi: 10.1007/s00428-021-03230-2. Epub 2021 Nov 11.

引用本文的文献

1
IL-6-mediated tumorigenicity and antioxidant state in squamous cell carcinoma cells are driven by CD109 via stabilization of IL-6 receptor-alpha and activation of STAT3/NRF2 pathway.白细胞介素-6介导的鳞状细胞癌细胞致瘤性和抗氧化状态是由CD109通过稳定白细胞介素-6受体α以及激活信号转导和转录激活因子3/核因子E2相关因子2途径驱动的。
Exp Hematol Oncol. 2025 May 2;14(1):64. doi: 10.1186/s40164-025-00630-x.
2
The application of Aptamer in biomarker discovery.适配体在生物标志物发现中的应用。
Biomark Res. 2023 Jul 19;11(1):70. doi: 10.1186/s40364-023-00510-8.
3
Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer.

本文引用的文献

1
Pathways of vulvar intraepithelial neoplasia and squamous cell carcinoma.外阴上皮内瘤变和鳞状细胞癌的途径。
Histopathology. 2013 Jan;62(1):161-75. doi: 10.1111/his.12034. Epub 2012 Nov 27.
2
Prognostic significance of c-KIT in vulvar cancer: bringing this molecular marker from bench to bedside.c-KIT 在外阴癌中的预后意义:将这一分子标志物从实验室带到临床。
J Transl Med. 2012 Jul 28;10:150. doi: 10.1186/1479-5876-10-150.
3
Human papillomavirus-associated cancers - United States, 2004-2008.人乳头瘤病毒相关性癌症 - 美国,2004-2008 年。
CD109表达在卵巢上皮癌患者中的预后意义
J Pathol Transl Med. 2019 Jul;53(4):244-252. doi: 10.4132/jptm.2019.04.16. Epub 2019 May 2.
4
Development of novel monoclonal antibodies against CD109 overexpressed in human pancreatic cancer.针对人胰腺癌中过表达的CD109开发新型单克隆抗体。
Oncotarget. 2018 Apr 13;9(28):19994-20007. doi: 10.18632/oncotarget.25017.
5
Association of down-regulation of CD109 expression with up-expression of Smad7 in pathogenesis of psoriasis.银屑病发病机制中CD109表达下调与Smad7表达上调的关联。
J Huazhong Univ Sci Technolog Med Sci. 2016 Feb;36(1):132-136. doi: 10.1007/s11596-016-1555-1. Epub 2016 Feb 3.
6
Elevated Expression of CD109 in Esophageal Squamous Cell Carcinoma.CD109在食管鳞状细胞癌中的表达升高。
Pathol Oncol Res. 2015 Sep;21(4):1273-5. doi: 10.1007/s12253-014-9894-3. Epub 2015 Jun 28.
7
CD109 is a potential target for triple-negative breast cancer.CD109是三阴性乳腺癌的一个潜在靶点。
Tumour Biol. 2014 Dec;35(12):12083-90. doi: 10.1007/s13277-014-2509-5. Epub 2014 Aug 23.
MMWR Morb Mortal Wkly Rep. 2012 Apr 20;61:258-61.
4
Trends in of late-stage squamous cell vulvar carcinomas: analysis of the surveillance, epidemiology, and end results (SEER) database.晚期鳞状细胞外阴癌的趋势:监测、流行病学和最终结果(SEER)数据库分析。
Int J Gynecol Cancer. 2012 Jun;22(5):854-9. doi: 10.1097/IGC.0b013e318249bce6.
5
Validation of the FIGO 2009 staging system for carcinoma of the vulva.FIGO 2009 外阴癌分期系统的验证。
Int J Gynecol Cancer. 2012 Mar;22(3):498-502. doi: 10.1097/IGC.0b013e318241d994.
6
Current management of vulvar cancer.外阴癌的现行治疗方法。
Hematol Oncol Clin North Am. 2012 Feb;26(1):45-62. doi: 10.1016/j.hoc.2011.10.006.
7
Clinico-pathological and biological prognostic variables in squamous cell carcinoma of the vulva.外阴鳞癌的临床病理和生物学预后变量。
Crit Rev Oncol Hematol. 2012 Jul;83(1):71-83. doi: 10.1016/j.critrevonc.2011.09.003. Epub 2011 Oct 19.
8
CD109-mediated degradation of TGF-β receptors and inhibition of TGF-β responses involve regulation of SMAD7 and Smurf2 localization and function.CD109 介导的 TGF-β 受体降解和 TGF-β 反应抑制涉及 SMAD7 和 Smurf2 定位和功能的调节。
J Cell Biochem. 2012 Jan;113(1):238-46. doi: 10.1002/jcb.23349.
9
Role of TP53 mutations in vulvar carcinomas.TP53 基因突变在外阴癌中的作用。
Int J Gynecol Pathol. 2011 Sep;30(5):497-504. doi: 10.1097/PGP.0b013e3182184c7a.
10
Does human papillomavirus infection imply a different prognosis in vulvar squamous cell carcinoma?人乳头瘤病毒感染是否意味着外阴鳞癌的预后不同?
Gynecol Oncol. 2011 Sep;122(3):509-14. doi: 10.1016/j.ygyno.2011.05.016. Epub 2011 Jun 8.